Co-Diagnostics (CODX) said late Thursday it closed a registered direct offering of over 9.6 million common shares at $0.40 apiece to two institutional investors for gross proceeds of around $3.8 million.
Net proceeds will be used for working capital and general corporate purposes, according to a statement.